Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03504410
Title Study Evaluating Efficacy and Safety of CPI-613 in Combination With HD Cytarabine and Mitoxantrone vs HD Cytarabine and Mitoxantrone in Older Patients With R/R AML
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Rafael Pharmaceuticals Inc.

acute myeloid leukemia


Cytarabine + Mitoxantrone

CPI-613 + Cytarabine + Mitoxantrone

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | BEL | AUT

No variant requirements are available.